Incidence of microbial infection associated with venous and urinary catheters in cancer patients

Mohamed Baayou; Eltaher Elshagmani; Fatma Enwji; Yasmine Abu-Shaala; Asmaa Qawasim; Aisha Al-Qasim; Firdaws Jalwal

المؤلفون

Mohamed Baayou Department of Medicine Faculty of Medicine Misurata university Libya
Eltaher Elshagmani Department of Medical Laboratories Faculty of Medical Technology Misurata Libya
Fatma Enwji Department of Pharmaceutical Technology Faculty of Medical Technology Misurata Libya
Yasmine Abu-Shaala Department of Microbiology, Ras Al-Sayeh Health Center
Asmaa Qawasim Department of Medical Laboratories Faculty of Medical Technology Misurata Libya
Aisha Al-Qasim Department of Medical Laboratories Faculty of Medical Technology Misurata Libya
Firdaws Jalwal Department of Medical Laboratories Faculty of Medical Technology Misurata Libya

الكلمات المفتاحية:

bacteria، antibiotic، catheter، infection، cancer patients

الملخص

Background: Cancer patients are highly susceptible to microbial infections, particularly those caused by multidrug-resistant (MDR) hospital-acquired bacteria. Such infections pose a serious threat to immunocompromised individuals and complicate treatment decisions. Understanding the epidemiology of these pathogens and their antibiotic susceptibility patterns is therefore essential for improving patient outcomes. This study aimed to identify microorganisms isolated from venous and urinary catheters in cancer patients and evaluate their susceptibility to commonly used antibiotics.

Methods: Catheter tip samples were collected from patients at the National Cancer Institute, representing both genders and a wide age range. Samples were cultured on Blood agar, MacConkey agar, and Chocolate agar, then incubated at 37°C for 24–48 hours. Bacterial identification was performed using Gram staining, catalase and coagulase tests for Gram-positive species, and biochemical tests and API 20E for Gram-negative species. Antibiotic susceptibility testing followed Clinical and Laboratory Standards Institute (CLSI) guidelines using routinely used antibiotics.

Results: Of 56 catheter samples (central lines: 28; Port-a-caths: 10; urinary catheters: 18), microbial growth was detected in 83.9%. Bacterial isolates represented 83.9% of positive samples, while fungal isolates accounted for 16.1%. Gram-positive bacteria were more common (58.1%) than Gram-negative (25.8%). Staphylococcus aureus (38.8%) was the predominant Gram-positive isolate, followed by Streptococcus spp. (9.6%), Bacillus spp. (6.5%), and Enterococcus faecalis (3.2%). Among Gram-negative bacteria, Klebsiella pneumoniae (12.9%) was most frequent, followed by Pseudomonas aeruginosa (6.5%), Serratia marcescens (3.2%), and Acinetobacter spp. (3.2%). S. aureus isolates showed high susceptibility to amikacin, imipenem, and ciprofloxacin, while K. pneumoniae isolates were largely susceptible to ciprofloxacin and meropenem.

Conclusion: The findings demonstrate clear differences in antibiotic susceptibility between Gram-positive and Gram-negative pathogens. Further research should investigate biofilm formation, which may reduce antibiotic efficacy.

السير الشخصية للمؤلفين

Yasmine Abu-Shaala، Department of Microbiology, Ras Al-Sayeh Health Center

Asmaa Qawasim، Department of Medical Laboratories Faculty of Medical Technology Misurata Libya

Firdaws Jalwal، Department of Medical Laboratories Faculty of Medical Technology Misurata Libya

المراجع

(1) Klastersky, J., et al., Bacteraemia in febrile neutropenic cancer patients. 2007. 30: p. 51-59.

(2) Velasco, E., et al., Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections. 2006. 25: p. 1-7.

(3) Rolston, K.V.J.I.d. and therapy, Infections in cancer patients with solid tumors: a review. 2017. 6: p. 69-83.

(4) Prathyusha, Y.H., A. Vara, and G.J.B. Suguneswari, Bacteriological profile of clinical isolates in cancer patients with febrile neutropenia in a tertiary care hospital in Kurnool, Andhra Pradesh. 8(29.6): p. 20.

(5) Aloush, S.M. and F.A.J.S.m.j. Alsaraireh, Nurses’ compliance with central line associated blood stream infection prevention guidelines. 2018. 39(3): p. 273.

(6) Bianco, A., et al., Prospective surveillance of healthcare-associated infections and patterns of antimicrobial resistance of pathogens in an Italian intensive care unit. 2018. 7: p. 1-6.

(7) Control, C.f.D. and Prevention, National Healthcare Safety Network (NHSN). Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection). 2018.

(8) Haddadin, Y., P. Annamaraju, and H. Regunath, Central Line–Associated Blood Stream Infections. 2017.

(9) Baier, C., et al., Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients. 2020. 15(1): p. e0227772.

(10) Zakhour, R., A.-M. Chaftari, and I.I.J.T.L.i.d. Raad, Catheter-related infections in patients with haematological malignancies: novel preventive and therapeutic strategies. 2016. 16(11): p. e241-e250.

(11) Laporte-Amargos, J., et al., Increasing gram-negative catheter-related bloodstream infection in cancer patients. 2023. 12(2): p. 228.

(12) Mermel, L.A., et al., Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. 2009. 49(1): p. 1-45.

(13) Benjamin Jr, D.K., et al., Bacteremia, central catheters, and neonates: when to pull the line. 2001. 107(6): p. 1272-1276.

(14) Tsai, H.-C., et al., Central venous catheter-associated bloodstream infections in pediatric hematology–oncology patients and effectiveness of antimicrobial lock therapy. 2015. 48(6): p. 639-646.

(15) Gao, Y., et al., The incidence and risk factors of peripherally inserted central catheter-related infection among cancer patients. 2015: p. 863-871.

(16) Assadi, F.J.I.j.o.p.m., Strategies for preventing catheter-associated urinary tract infections. 2018, Medknow. p. 50.

(17) Kazi, M.M., et al., Catheter associated urinary tract infections (CAUTI) and antibiotic sensitivity pattern from confirmed cases of CAUTI in a tertiary care hospital: A prospective study. 2015. 4(193): p. 2.

(18) Parida, S. and S.K.J.I.j.o.c.c.m.p.-r. Mishra, official publication of Indian Society of Critical Care Medicine, Urinary tract infections in the critical care unit: A brief review. 2013. 17(6): p. 370.

(19) Barry, A.L.J.A.s.t.p., An overview of the Clinical and Laboratory Standards Institute (CLSI) and its impact on antimicrobial susceptibility tests. 2007. 1.

(20) Zheng, Z., et al., Analysis of nosocomial infection characteristics in cancer patients after interventional therapy of 10 years: a retrospective study from 2013 to 2022. 2025. 25(1): p. 829.

(21) Çeken, S., et al., Bloodstream infections in older cancer patients: epidemiology and risk factors for mortality. 2025. 19(08): p. 1205-1215.

(22) MacPhail, A., et al., Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland. 2025: p. 1-11.

(23) Ahmed, B., et al., Frequency of Central Venous Catheter Related Infections and their Culture and Sensitivity Pattern. 2016. 5(2): p. 63-66.

(24) de Dios-García, B., et al., Bacteremia in Patients with Solid Organ Cancer: Insights into Epidemiology and Antibiotic Consumption. 2023. 15(23): p. 5561.

(25) Zhang, Y., et al., Incidence rate, pathogens and economic burden of catheter-related bloodstream infection: A single-center, retrospective case-control study. 2023: p. 3551-3560.

(26) Hoceini, A., et al., Evaluation of Biofilm Forming Potential and Antimicrobial Resistance Profile of and Isolated from Peripheral Venous Catheters and Urinary Catheters in Algeria, in vitro Study. 2023. 7(1): p. 83-92.

(27) Al-Hazmi, H.J.R. and r.i. urology, Role of duration of catheterization and length of hospital stay on the rate of catheter-related hospital-acquired urinary tract infections. 2015: p. 41-47.